Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
2178049-58-4
Purity
95%
ACT-1004-1239 is a potent, selective, orally available atypical chemokine receptor 3 (CXCR7) antagonist with an IC50 value of 0.6 nM.
Properties
Name
ACT-1004-1239
Smiles
FC=1C=CC(C2=CC(=NO2)C(=O)N[C@H]3CCN(CC4CC4)C[C@@H]3C(=O)NC5(CC5)C=6N=CC=CN6)=C(F)C1
Targets
Please log in to see this information
SDS
ACT-1004-1239
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$250
2 mg
$375
5 mg
$750
10 mg
$1299
15 mg
$1575
20 mg
$1848
25 mg
$2248
30 mg
$2647
35 mg
$3047
40 mg
$3447
45 mg
$3696
50 mg
$3946
75 mg
$5244
100 mg
$POA
Quantity
1
Total amount
$ 750
ACT-1004-1239
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.